Jessica Thurmond and Monica Schmiede, co-CEOs and co-founders of Athelo Health — the first biometric-anchored virtual coach for women with breast and gynecologic cancers — join McGuireWoods partner Kristen McDermott Woodrum on this episode of Health+Tech. They discuss Athelo Health’s mission, how Athelo Health uses biometric data to support patients, and the role of
Notable Litigation – July 2023
Notable litigation filed during July 2023 includes: (1) O’Keefe v. Multicoin Cap. Mgmt. LLC; (2) Bledsoe v. Order of Magnitude Ventures LLC; (3) O’Keefe v. Farmington State Bank; and (4) SEC v. Tadrus.
Massachusetts Attorney General Increasing Enforcement in Car Repossession Space
The Massachusetts Attorney General (AG) is increasing its enforcement in the motor-vehicle-repossession space. In a January 17, 2023 Assurance of Discontinuance (AOD), the AG stated that it is “conducting an investigation” into “entities collecting, servicing and/or funding” motor-vehicle-secured retail-installment contracts. The AG is focused on two primary areas of compliance:
- the content of the pre-sale and post-sale repossession notices and, in particular, that the notices include a statement that a customer’s deficiency after auctioning their vehicle would be based on the vehicle’s fair-market value; and
- the frequency of phone calls to debtors and whether those calls exceed the limits prescribed by 940 CMR 7.04(1)(f).
Upcoming McGuireWoods Healthcare & Life Sciences Events to Know
McGuireWoods is hosting three upcoming healthcare and life sciences events you will want to know about and attend. Click on the event title to learn more and register.
Women’s Health: Regulatory Updates and Key TopicsThis complimentary webinar, scheduled for Wednesday, August 30, will be presented by Kayla McCann Marty and Sydney Menack. They will…
Healthcare & Life Sciences Private Equity Deal Tracker: Cressey Acquires HealthDrive
Cressey & Company has announced it has acquired HealthDrive from Bain Capital Double Impact.
HealthDrive, based in Framingham, Mass., is a multi-specialty clinical services organization to patients residing in long-term care facilities. Founded in 1989, the company states it employs more than 500 clinicians in more than 3,800 facilities,
Cressey, with offices in…
Healthcare & Life Sciences Private Equity Deal Tracker: InTandem Invests in OrthoNebraska
InTandem Capital Partners has announced it has completed an investment in OrthoNebraska.
OrthoNebraska, based in Omaha, Neb., is a regional provider of orthopedic and musculoskeletal care. Founded in 2004, the organization has locations in Nebraska, Iowa and Missouri that provide surgical and non-surgical intervention, supported by a range of sub-specialized providers.
InTandem, based…
Healthcare & Life Sciences Private Equity Deal Tracker: Coalesce Capital Recapitalizes Examinetics
Coalesce Capital has announced it has participated in a recapitalization of Examinetics.
Examinetics, founded in 2004 and based in Overland Park, Kan., is a provider of mobile occupational health screening services, tests and data management.
Coalesce, based in New York, is a middle market private equity firm focused on investing in human capital…
Healthcare & Life Sciences Private Equity Deal Tracker: BV Invests in Hardenbergh Group
BV Investment Partners has announced it has invested in Hardenbergh Group.
Hardenbergh Group, founded in 1991 and based in Livonia, Mich., is a provider of non-clinical professional staffing, consulting, physician peer review and outsourced solutions to U.S. healthcare organizations.
BV, based in Boston, is a middle market private equity firm focused on the…
Healthcare & Life Sciences Private Equity Deal Tracker: Kohlberg to Acquire Worldwide Clinical Trials
Kohlberg & Company will acquire Worldwide Clinical Trials, according to a news release.
Worldwide, based in Research Triangle Park, N.C., is a full-service contract research organization. Founded in 1986, Worldwide, an affiliate company of private equity firm TJC, partners with biotechnology and pharmaceutical companies to create solutions designed to advance new medications.
Top Five Considerations for Senior Housing M&A
Despite a decline in overall senior housing M&A activity from 2022 to 2023, nonprofit M&A is pacing for a record year.[1] Many of the same market conditions that cooled overall M&A activity — such as increasing interest rates, tightened lending requirements and operational uncertainty — appear to be causing a surge in nonprofit affiliations,…